Yonsei University College of Medicine Research Team Confirms Ovulation-Induction Effect in Animal Study
FSH Gradually Released Over 3 Days; Heat Triggers Rapid hCG Delivery

A drug-delivery technology has been developed that could reduce the burden of repeated hormone injections during fertility treatment.


Microneedle Requiring Just One Insertion Developed to Ease the Burden of Hormone Injections for Infertility Treatment View original image

A research team comprising Professors Seong Hakjun, Cho Seongwoo and Yoo Seungeun and student Kim Hyeonjae of the Department of Medical Engineering at Yonsei University College of Medicine, along with Professor Choi Youngsik of the Department of Obstetrics and Gynecology at Severance Hospital, developed shape-memory microneedles, the team announced on October 26.


During the ovarian stimulation process for fertility treatment, patients receive follicle-stimulating hormone (FSH), which promotes follicle growth, and human chorionic gonadotropin (hCG), which triggers ovulation, according to a set schedule and dosage. Since these hormones are mostly administered by subcutaneous injection, repeated shots can cause pain and discomfort, and patients also have the burden of keeping track of when to administer them.


The research team developed microneedles that control drug release by using a shape-memory polymer that returns to its original shape in response to temperature changes. FSH and hCG are loaded into separate compartments inside the microneedles, allowing the two hormones to be delivered at different times.


When the microneedles are inserted into the skin, FSH is released gradually over three days. Then, applying heat at a level comparable to that of a hot pack triggers the rapid release of the hCG stored inside. A single insertion of the microneedles delivers the two hormones at different times and rates.


Using computer simulations, the team designed a structure suitable for penetrating the skin and carrying the drugs. Cell and tissue experiments confirmed that temperature-induced changes in the microneedles' shape regulate drug release.


In animal experiments using rabbits, a single insertion of the microneedles successfully delivered FSH continuously, followed by rapid delivery of hCG after heat was applied at a predetermined time. Compared with a control group that received repeated hormone injections, the microneedles mitigated sharp fluctuations in hormone levels while producing an ovulation-induction effect similar to that of conventional injection therapy.


Professor Seong Hakjun said, "This study presents a new approach that uses changes in the shape of microneedles to alter how drugs are delivered when needed. We plan to develop this into a platform technology that can reduce the burden of repeated injections on patients and be applied to a range of treatments requiring the sequential delivery of multiple drugs."



The findings were published in the international journal Advanced Functional Materials (impact factor: 19.9).


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing